Evidence map›Paper›PMID 42420825›Full record

ArticleBMC microbiology2026

Antimicrobial resistance and plasmidome of carbapenemase-resistant Klebsiella pneumoniae causing bloodstream infections between 2014 and 2024.

Wentao Zhu, Qian Liu, Hong Shen, Xi Chen, Chunxia Yang, Ming Wei, Li Gu

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BMC microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Wentao Zhu *Department of Infectious Diseases and Clinical Microbiology, Beijing Chao-Yang Hospital, Capital Medical University, No.8, Gongti South Road, Beijing, 100020, PR China. wentaozhu@126.com.
Qian Liu *Department of Clinical Laboratory, Beijing Anzhen Hospital, Capital Medical University, Beijing, 100029, PR China.
Hong ShenDepartment of Infectious Diseases and Clinical Microbiology, Beijing Chao-Yang Hospital, Capital Medical University, No.8, Gongti South Road, Beijing, 100020, PR China.
Xi ChenDepartment of Infectious Diseases and Clinical Microbiology, Beijing Chao-Yang Hospital, Capital Medical University, No.8, Gongti South Road, Beijing, 100020, PR China.
Chunxia YangDepartment of Infectious Diseases and Clinical Microbiology, Beijing Chao-Yang Hospital, Capital Medical University, No.8, Gongti South Road, Beijing, 100020, PR China.
Ming WeiDepartment of Infectious Diseases and Clinical Microbiology, Beijing Chao-Yang Hospital, Capital Medical University, No.8, Gongti South Road, Beijing, 100020, PR China.
Li GuDepartment of Infectious Diseases and Clinical Microbiology, Beijing Chao-Yang Hospital, Capital Medical University, No.8, Gongti South Road, Beijing, 100020, PR China. didcm2006@mail.ccmu.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The WHO has designated carbapenemase-resistant Klebsiella pneumoniae (CRKP) as a priority pathogen due to the potential for nosocomial infection outbreaks. In this study, a total of 724 non-duplicated K. pneumoniae bloodstream infection isolates were collected in Beijing between 2014 and 2024, of which 14.5% were identified as CRKP (n = 105). The incidence of CRKP isolates remained at a relatively high level since 2018, with a significant increase observed following the SARS-CoV-2 epidemic. The most common sequence type was ST11 (84.8%), followed by ST16 (5.7%) and ST15 (5.7%). Sixteen potential clonal transmissions were identified, including four clonal clusters transmitted at the ward-level. Antimicrobial resistance was severe, with almost all isolates showing resistance to 15 antimicrobials tested. The bla

Indexed as

BacteremiaBacterial Proteinsbeta-LactamasesKlebsiella InfectionsKlebsiella pneumoniaePlasmidsAnti-Bacterial AgentsBeijingCross InfectionDrug Resistance, Multiple, BacterialHumansMicrobial Sensitivity TestsAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasescarbapenemaseAntimicrobial resistanceBloodstream infectionCarbapenemase-resistantKlebsiella pneumoniaePlasmid

Identifiers

PMID42420825
PMCPMC13374322

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.